TCG Crossover GP II, LLC Reports New 5.2% Stake in Vor Biopharma Inc.

On April 1, 2026, TCG Crossover GP II, LLC filed a Schedule 13G reporting a new 5.2% stake in Vor Biopharma Inc. (VOR). The filing reveals that TCG Crossover GP II, LLC beneficially owns 2,836,539 shares of Common Stock. This position is part of a larger joint filing involving TCG Crossover Fund II, L.P., TCG Crossover Fund III, L.P., and Chen Yu. Specifically, TCG Crossover II and TCG Crossover III each hold 2,836,539 shares. Chen Yu, as the sole managing member of the general partners for both funds, is deemed to have shared voting and dispositive power over a total of 5,673,078 shares, representing a 10.5% aggregate ownership interest. The calculation of these percentages is based on 54,185,582 shares outstanding, which includes shares from an underwritten offering that closed on March 30, 2026. The reporting persons have certified that these shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.